Exchange: NASDAQ·Updated 10:05 PM EDT
News
all
press releases
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million. BeyondSpring (NASDAQ:BYSI) shares movedread more...
Benzinga
More News
Liminatus Pharma Buys More Time, September 3 Deadline is Now the Catalyst
Liminatus Pharma (NASDAQ:LIMN) has cleared one immediate Nasdaq hurdle, but the clock is still running. The company announced that its common stock transferred from the Nasdaq Global Market to the Nasdaq Capital Market effective August 4, 2026, while the Nasdaq Hearings Panel granted Liminatus additional time to regain compliance with the exchange’s minimum bid price requirement. The new deadline is September 3, 2026, giving the company several more weeks to demonstrate compliance while allowing LIMN to continue trading on Nasdaq under its existing ticker.
24-7 Market News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares increased byread more...
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's regular session. The company's market cap stands at $7.6 million. Agape ATP (NASDAQ:ATPC) shares moved upwards byread more...
Benzinga
11 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million. Liminatus Pharma (NASDAQ:LIMN)read more...
Benzinga
Liminatus Pharma (LIMN) Stock Is Trending Overnight Here's Why it Spiked Over 30% in After-Hours Session (UPDATED)
Liminatus Pharma shares surged 30.49% in after-hours trading following an amended InnocsAI merger deal that speeds up closing.read more...
Benzinga
The Biotech Repricing Wave May Be Starting as Capital Pours into High-Impact Oncology Platforms
Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital raises, pipeline expansions, analyst initiations, and oncology breakthroughs reshapes momentum across the sector. $NTHI, $IMMX, $RLAY, $AKTX, $LIMN
24-7 Market News
Liminatus Pharma Is Trending Overnight Here's Why LIMN Stock Surged Over 79% In After-Hours Session
Liminatus Pharma Inc. shares soared in after-hours trading after the company announced a merger agreement with InnocsAI LLC.read more...
Benzinga
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance
The company had previously faced a notice for delayed filings but has since rectified the issue.
Stocktwits

Advertisement|Remove ads.